180 related articles for article (PubMed ID: 16129814)
1. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice.
Matsuki T; Isoda K; Horai R; Nakajima A; Aizawa Y; Suzuki K; Ohsuzu F; Iwakura Y
Circulation; 2005 Aug; 112(9):1323-31. PubMed ID: 16129814
[TBL] [Abstract][Full Text] [Related]
2. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.
Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y
J Immunol; 2010 Aug; 185(3):1887-93. PubMed ID: 20610641
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
[TBL] [Abstract][Full Text] [Related]
4. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
[TBL] [Abstract][Full Text] [Related]
6. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
[TBL] [Abstract][Full Text] [Related]
7. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
8. Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor.
Shepherd J; Nicklin MJ
Circulation; 2005 Jun; 111(23):3135-40. PubMed ID: 15939811
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.
Isoda K; Shiigai M; Ishigami N; Matsuki T; Horai R; Nishikawa K; Kusuhara M; Nishida Y; Iwakura Y; Ohsuzu F
Circulation; 2003 Aug; 108(5):516-8. PubMed ID: 12874179
[TBL] [Abstract][Full Text] [Related]
12. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/c mice.
Isoda K; Matsuki T; Kondo H; Iwakura Y; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):708-15. PubMed ID: 20110570
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
Krelin Y; Voronov E; Dotan S; Elkabets M; Reich E; Fogel M; Huszar M; Iwakura Y; Segal S; Dinarello CA; Apte RN
Cancer Res; 2007 Feb; 67(3):1062-71. PubMed ID: 17283139
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
Yang SY; Wu B; Mayton L; Mukherjee P; Robbins PD; Evans CH; Wooley PH
Gene Ther; 2004 Mar; 11(5):483-91. PubMed ID: 14724688
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
17. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
19. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
[TBL] [Abstract][Full Text] [Related]
20. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
